ID

14288

Beschrijving

Treatment of Ragweed-Allergic Asthma With an Immunostimulatory Drug; ODM derived from: https://clinicaltrials.gov/show/NCT00318747

Link

https://clinicaltrials.gov/show/NCT00318747

Trefwoorden

  1. 07-04-16 07-04-16 -
Houder van rechten

CC BY-NC 3.0

Geüploaded op

7 april 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Asthma NCT00318747

Eligibility Asthma NCT00318747

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00318747
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
history of asthma
Beschrijving

history of asthma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0004096
history of asthma medication use during the 2005 fall ragweed season
Beschrijving

asthma medication use

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0004096
suspected ragweed allergy
Beschrijving

ragweed allergy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0440357
positive laboratory tests for ragweed allergy
Beschrijving

positive laboratory tests for ragweed allergy

Datatype

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0440357
UMLS CUI [1,3]
C0022885
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
received immunotherapy for ragweed or other allergens within the 5 years prior to study entry
Beschrijving

immunotherapy for ragweed or other allergens

Datatype

boolean

Alias
UMLS CUI [1,1]
C0021083
UMLS CUI [1,2]
C0440357
received anti-ige (omalizumab) within the year prior to study entry
Beschrijving

omalizumab

Datatype

boolean

Alias
UMLS CUI [1,1]
C0966225
UMLS CUI [1,2]
C0040223
3 or more courses of oral corticosteroids for asthma within the year prior to study entry
Beschrijving

oral corticosteroids

Datatype

boolean

Alias
UMLS CUI [1,1]
C0001617
UMLS CUI [1,2]
C0040223
inpatient hospitalization for asthma within the 5 years prior to study entry
Beschrijving

hospitalization for asthma

Datatype

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0004096
UMLS CUI [1,3]
C0040223
history of respiratory failure or intubation for asthma
Beschrijving

respiratory failure or intubation

Datatype

boolean

Alias
UMLS CUI [1]
C1145670
UMLS CUI [2]
C0021925
smoking within the 6 months prior to study entry
Beschrijving

smoking

Datatype

boolean

Alias
UMLS CUI [1]
C1519384
greater than 5 pack/year history of smoking
Beschrijving

pack years

Datatype

boolean

Alias
UMLS CUI [1]
C1277691
clinically significant acute or chronic illness
Beschrijving

clinically significant acute or chronic illness

Datatype

boolean

Alias
UMLS CUI [1]
C0009488
chronic immunodeficiency
Beschrijving

immunodeficiency

Datatype

boolean

Alias
UMLS CUI [1]
C0021051

Similar models

Eligibility Asthma NCT00318747

  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT00318747
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
history of asthma
Item
history of asthma
boolean
C0262926 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
asthma medication use
Item
history of asthma medication use during the 2005 fall ragweed season
boolean
C0013227 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
ragweed allergy
Item
suspected ragweed allergy
boolean
C0020517 (UMLS CUI [1,1])
C0440357 (UMLS CUI [1,2])
positive laboratory tests for ragweed allergy
Item
positive laboratory tests for ragweed allergy
boolean
C0020517 (UMLS CUI [1,1])
C0440357 (UMLS CUI [1,2])
C0022885 (UMLS CUI [1,3])
Item Group
C0680251 (UMLS CUI)
immunotherapy for ragweed or other allergens
Item
received immunotherapy for ragweed or other allergens within the 5 years prior to study entry
boolean
C0021083 (UMLS CUI [1,1])
C0440357 (UMLS CUI [1,2])
omalizumab
Item
received anti-ige (omalizumab) within the year prior to study entry
boolean
C0966225 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
oral corticosteroids
Item
3 or more courses of oral corticosteroids for asthma within the year prior to study entry
boolean
C0001617 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
hospitalization for asthma
Item
inpatient hospitalization for asthma within the 5 years prior to study entry
boolean
C0019993 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C0040223 (UMLS CUI [1,3])
respiratory failure or intubation
Item
history of respiratory failure or intubation for asthma
boolean
C1145670 (UMLS CUI [1])
C0021925 (UMLS CUI [2])
smoking
Item
smoking within the 6 months prior to study entry
boolean
C1519384 (UMLS CUI [1])
pack years
Item
greater than 5 pack/year history of smoking
boolean
C1277691 (UMLS CUI [1])
clinically significant acute or chronic illness
Item
clinically significant acute or chronic illness
boolean
C0009488 (UMLS CUI [1])
immunodeficiency
Item
chronic immunodeficiency
boolean
C0021051 (UMLS CUI [1])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial